Reported results
- Net sales were $35.5 million for the third quarter of 2026.
- Durable Medical Equipment (DME) channel net sales were $21.9 million.
- Pharmacy Benefit Plan (PBP) channel net sales were $13.6 million.
- Gross margin was 57.3% for the third quarter of 2026.
- Loss from operations was $26.6 million for the third quarter of 2026.
- Adjusted EBITDA was negative $18.9 million for the third quarter of 2026.
Guidance
- Estimated total revenue of approximately $124 million to $126 million for the full year 2026.
- Estimated 37% to 39% of new patient starts reimbursed through the PBP channel.
- Estimated gross margin of 58.5% to 59.5%.
Notes
Quality system remediation expenses were previously labeled ‘Other non-recurring’ in the Form 10-K for the year ended December 31, 2025.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.
